Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 126, Issue 6, Pages 2249-2253Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI84360
Keywords
-
Categories
Funding
- Swedish Research Council
- Knut and Alice Wallenberg Foundation
- Bertil Hasten Foundation
- Torsten and Ragnar Soderberg Foundation
- Swedish Brain Fund
- Stratneuro Initiative
- Vasterbotten County Council
- Kempe Foundations
Ask authors/readers for more resources
Amyotrophic lateral sclerosis (ALS) is an adult-onset degeneration of motor neurons that is commonly caused by mutations in the gene encoding superoxide dismutase 1 (SOD1). Both patients and Tg mice expressing mutant human SOD1 (hSOD1) develop aggregates of unknown importance. In Tg mice, 2 different strains of hSOD1 aggregates (denoted A and B) can arise; however, the role of these aggregates in disease pathogenesis has not been fully characterized. Here, minute amounts of strain A and B hSOD1 aggregate seeds that were prepared by centrifugation through a density cushion were inoculated into lumbar spinal cords of 100-day-old mice carrying a human SOD1 Tg. Mice seeded with A or B aggregates developed premature signs of ALS and became terminally ill after approximately 100 days, which is 200 days earlier than for mice that had not been inoculated or were given a control preparation. Concomitantly, exponentially growing strain A and B hSOD1 aggregations propagated rostrally throughout the spinal cord and brainstem. The phenotypes provoked by the A and B strains differed regarding progression rates, distribution, end-stage aggregate levels, and histopathology. Together, our data indicate that the aggregate strains are prions that transmit a templated, spreading aggregation of hSOD1, resulting in a fatal ALS-like disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available